Incentives can create genuine adherence in cardiometabolic care – or waste budget on behaviors that improve no outcomes. We design loyalty and rewards programs that advance the metrics that matter, withstand gaming, and avoid the compliance boundaries health incentives can cross.
The Issue
You incentivize activity that resembles health but produces no outcome
It is easy to hand out points for logging a meal or opening the app, and easy to feel good about the engagement numbers that result. But activity is not adherence, and a program that rewards taps generates a spike of gaming – members doing the minimum to earn the reward – while A1C and blood pressure do not budge. Paying for vanity engagement is worse than paying for nothing, because it hides the retention problem behind a busy dashboard.
Health incentives may cross regulatory and fraud-and-abuse boundaries
Rewards in a cardiometabolic context are not the same as airline miles. Depending on how the program is funded and structured, incentives can implicate healthcare fraud-and-abuse rules, wellness-program regulations, and payer contract terms. A loyalty program designed by a marketer who has never touched healthcare compliance can create real legal exposure, and companies either avoid incentives entirely or build them naively and hope no one asks the hard questions.
You reward behavior members would have completed regardless
The most motivated members – the ones already adherent – are the quickest to enroll in a rewards program, which means a poorly targeted program spends its budget subsidizing behavior that needed no incentive. The members who actually need a nudge, the ones drifting toward lapse, are the hardest to reach and the least likely to opt in. Without incremental design, loyalty becomes a giveaway to your best members and a miss on the ones at risk.
External rewards can displace the intrinsic motivation that care relies on
Chronic-disease management is sustained by intrinsic motivation – feeling better, taking control of one's health. Clumsy extrinsic rewards can undermine that, turning health behaviors into transactions that stop the moment the points do. A cardiometabolic loyalty program that ignores behavior-change science risks buying short-term compliance while eroding the durable motivation that keeps members healthy for years, which is exactly backwards for a business built on long-term outcomes.
Our Approach
We begin by defining what the program can legitimately reward: outcomes and behaviors tied to outcomes, rather than vanity activity. Using your clinical model, we identify the behaviors that truly predict adherence and improvement – consistent CGM use, care-plan milestones, and genuine logging that demonstrates engagement – and build incentives around them. Rewarding what improves A1C instead of what boosts a dashboard is the first and most critical design choice, and it is where naive programs go wrong.
We engineer the program to withstand gaming. That requires basing rewards on sustained behavior and verified signals instead of easily farmed taps, then pressure-testing each mechanic against how a rational member might exploit it. In cardiometabolic care, gaming costs more than wasted budget – it also creates a false picture of retention – so anti-gaming design is essential, not optional.
We design around incrementality by focusing on members whose behavior a nudge can actually change. Instead of subsidizing people who are already adherent, we structure the program to reach members moving toward lapse, where an incentive can meaningfully shift behavior. That separates a rewards budget that purchases health from one that simply funds giveaways for people who needed no help.
We apply behavior-change science so external rewards reinforce, rather than replace, intrinsic motivation – using incentives to establish habits that continue after rewards end, recognizing genuine progress, and avoiding transactional framing that causes healthy behavior to cease when the points disappear. For a company built around multi-year outcomes, preserving lasting motivation is the central objective.
We also embed compliance from day one, collaborating with your legal and regulatory partners to keep the program clear of fraud-and-abuse, wellness-regulation, and payer-contract boundaries. Our difference is that we work as incentive designers who understand healthcare compliance and behavior-change science, while connecting rewards with your lifecycle and product efforts so everything supports the same adherence objective. The result is a rewards program that improves real outcomes, withstands gaming, reaches the right members, and stands up to scrutiny.
What we deliver
- Outcome-linked incentive design based on your clinical model, not vanity activity
- Anti-gaming program structure pressure-tested against real member behavior
- Incrementality-targeted design that reaches at-risk, not already-adherent, members
- Behavior-change framing that protects intrinsic motivation
- Compliance-vetted program structure clear of fraud-and-abuse and wellness-regulation lines
A cardiometabolic rewards program should not simply create more engagement—it should increase adherence among members who might otherwise lapse. Reward outcomes, focus on incremental impact, and preserve the intrinsic motivation that supports health after the points end.
Our Methodology
We use a focused build process. Phase one covers design: working from your clinical model, we define outcome-linked behaviors, structure for anti-gaming and incrementality, and review the entire program for compliance with your legal and regulatory partners. Phase two is launch and instrumentation, beginning with a targeted segment so we can assess genuine behavioral impact before expanding. The final phase evaluates incremental adherence effects, improves the mechanics, and transitions the program to your team.
Unlike a consumer loyalty agency, we design for outcomes and compliance within chronic disease, not points-and-tiers participation. Consumer loyalty firms optimize program participation; we optimize incremental adherence among at-risk members while preserving intrinsic motivation and avoiding healthcare regulatory issues – a fundamentally different challenge. We link rewards with your product and lifecycle work so incentives strengthen, rather than compete against, the rest of your retention strategy.
The program is created for your team to own and defend. By the end, the incentive model, anti-gaming structure, and compliance framework belong to you. We would rather create a program that withstands scrutiny than operate a rewards engine you cannot explain to a regulator.
Our Process
Phase one focuses on design and compliance alongside your clinical and legal partners, because an indefensible rewards program remains a liability regardless of performance. During the first several weeks, you will receive an outcome-linked incentive design and a compliance structure reviewed against applicable healthcare rules.
Our team provides an incentive designer experienced in behavior-change science and healthcare compliance, along with analytics support for measuring incrementality. We need your clinical lead to identify outcome-linked behaviors, your legal and regulatory partners to review the structure, and a product or data partner to instrument and validate rewarded actions. This cross-functional involvement keeps the program safe as well as effective.
During design, the cadence centers on working sessions, followed by a measured rollout to a targeted segment and weekly reviews of behavioral impact before deciding whether to scale. We intentionally avoid a big-bang launch so incremental effects on adherence can be demonstrated rather than presumed.
Engagements generally span three to five months across design, launch, and measurement. At completion, you have an outcome-focused rewards program, anti-gaming structure, compliance framework, and measurement demonstrating incremental adherence. Many clients continue to scale the program or extend it across conditions.
- Incremental adherence among at-risk members
- Reduced reward budget lost to gaming
- Compliance-safe incentive structure
- Preserved long-term intrinsic motivation
If your diabetes & cardiometabolic health company needs loyalty & rewards leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a loyalty and rewards engagement cost a cardiometabolic company?
Our design and build fee is structured as a monthly engagement lasting three to five months and is separate from the rewards budget. The fee is lower than the cost of a poorly designed program that loses budget to gaming or introduces compliance exposure – either can far exceed the design fee.
How soon will a rewards program begin showing results?
You will receive a vetted program design in the first several weeks, followed soon afterward by a measured launch to a targeted segment. Since we intentionally validate incremental adherence effects before scaling, meaningful adherence signals from that targeted rollout emerge over the next couple of months.
How do you maintain healthcare regulatory compliance in a rewards program?
We build the program with your legal and regulatory partners from the outset, keeping its structure clear of healthcare fraud-and-abuse requirements, wellness-program regulations, and payer-contract terms – limitations consumer loyalty programs do not face. The funding and framing of incentives matter enormously, so we resolve those choices before launch instead of uncovering issues afterward.
How does your rewards team work with our clinical and product teams?
We partner directly with your clinical lead to identify outcome-linked behaviors worth incentivizing, your legal partners to review the structure, and your product or data team to instrument and validate rewarded behavior. Rewards integrate with your lifecycle and product efforts so they support the same adherence objective rather than competing with it.
How is Winston Francois distinct from a conventional loyalty agency?
Traditional loyalty agencies create points-and-tiers programs that maximize participation. We focus on incremental adherence in chronic disease – rewarding outcomes instead of vanity activity, preventing gaming, reaching at-risk members, preserving intrinsic motivation, and remaining clear of healthcare regulation.
How is ROI measured for a rewards engagement?
We track incremental adherence – the gains among members who might otherwise lapse – rather than overall engagement, which any giveaway can boost. By launching with a targeted segment and measuring it against a comparison, we isolate the reward's true impact and determine the budget efficiency of reaching at-risk members.
Which cardiometabolic companies are best suited to this service?
The strongest fit is a Series A through growth-stage diabetes or cardiometabolic company with an active member base, a well-defined clinical model for driving outcomes, and a retention problem that incentives may address. If you cannot yet identify which behaviors predict adherence, that clinical clarity must come first, and we will tell you. The initial step is a call to determine whether a thoughtfully designed incentive program is the appropriate lever for your retention challenge.
